Know the science before you write the check.
Independent scientific due diligence and strategic guidance for investors in life sciences, biotech, and deep tech. We go past the pitch deck into the data, the technology, and the risks, then translate it all into clear investment insight.
Scientific clarity at every stage of the investment.
Scientific due diligence
A rigorous, independent review of the science behind a deal: does it work, is it differentiated, and can it scale?
- Review of data, methods, and reproducibility
- Technology readiness and development risk
- Competitive and IP landscape overview
- Regulatory and commercialization pathway
Deep-dive translation
We take your team into the scientific details, in plain language, so partners and investment committees understand exactly what they are buying.
- Briefings for partners and ICs
- Expert questions for management meetings
- Glossaries and technology primers
Investment thesis & strategy
Shape where you invest, not just what you invest in.
- Sector and technology landscape maps
- Thesis development and validation
- Deal-flow sourcing criteria
Portfolio value creation
Support after the close to help portfolio companies reach their milestones.
- Go-to-market and partnering support
- Board and management advisory
- Market entry and government-contracting strategy
A clear, decision-ready answer.
Every diligence engagement ends with a concise written assessment built for decision-makers: what is strong, what is uncertain, what could break the thesis, and what to ask next.
- Executive summary with a clear risk rating
- Key scientific strengths and red flags
- Questions and milestones to tie to funding
- Live debrief with your deal team or investment committee
Test it before you fund it.
Sometimes the right answer to a promising deal is "show me." Through our partner network of accredited laboratories, we can arrange independent verification and validation of a company's key claims, or a focused proof of principle tied to your next tranche.
- Independent replication of a key result
- Milestone-based studies that de-risk follow-on funding
- A clear, documented answer your committee can rely on
Fast, focused, and confidential.
Scope
A short call to define the deal, the key questions, and your timeline. We are happy to sign your NDA.
Deep dive
We review the data room, literature, and technology, and speak with management where helpful.
Findings
You receive a written assessment and a live debrief with your team.
Ongoing support
Optional follow-on support through term sheet, close, and portfolio growth.
Frequently asked
How quickly can you turn around a diligence review?
Timelines depend on scope and data-room readiness. Focused reviews can often be completed within a few weeks, and we will agree on a timeline that fits your deal before we begin.
Do you work on one deal at a time or on retainer?
Both. Many clients start with a single deal and move to a retainer for ongoing deal flow and portfolio support.
How do you handle confidentiality and conflicts?
All engagements are confidential. We sign NDAs and disclose any potential conflicts before accepting work.
Is this investment advice?
No. We provide scientific, technical, and strategic analysis to inform your team's own investment decisions. We do not provide financial, legal, or securities advice.
Evaluating a deal right now?
Book a 30-minute call to scope your questions. We will tell you honestly whether and how we can help.